Literature DB >> 2501497

Cross-reaction of immune sera from patients with rickettsial diseases.

K E Hechemy1, D Raoult, J Fox, Y Han, L B Elliott, J Rawlings.   

Abstract

Rickettsia rickettsii and Rickettsia conorii are the causative agents of two common and serious diseases, Rocky Mountain spotted fever and Mediterranean spotted fever, respectively. In patients naturally infected with either of these organisms, antibodies are produced which cross-react with antigens of the other so extensively that diagnostic tests usually cannot identify the causative agents. The results of this study indicate that serodiagnostic tests with antigen from one of these two organisms could be used to detect antibodies in patients with either of the two rickettsial diseases.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2501497     DOI： 10.1099/00222615-29-3-199

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN： 0022-2615            Impact factor:   2.472


  25 in total

1.  Rickettsia massiliae in ticks removed from humans in Castilla y León, Spain.

Authors:  P Fernández-Soto; R Pérez-Sánchez; V Díaz Martín; A Encinas-Grandes; R Alamo Sanz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-12       Impact factor: 3.267

Review 2.  Rickettsia australis and Queensland Tick Typhus: A Rickettsial Spotted Fever Group Infection in Australia.

Authors:  Adam Stewart; Mark Armstrong; Stephen Graves; Krispin Hajkowicz
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

3.  Effects of homologous and heterologous immunization on the reservoir competence of domestic dogs for Rickettsia conorii (israelensis).

Authors:  M L Levin; G E Zemtsova; M Montgomery; L F Killmaster
Journal:  Ticks Tick Borne Dis       Date:  2013-11-05       Impact factor: 3.744

4.  Use of enzyme-linked immunosorbent assay techniques with cross-reacting human sera in diagnosis of murine typhus and spotted fever.

Authors:  A Keysary; C Strenger
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

5.  Seroepidemiologic study of human infections with spotted fever group Rickettsiae in North Carolina.

Authors:  Meagan F Vaughn; Josie Delisle; Joey Johnson; Gaylen Daves; Carl Williams; Jodi Reber; Nicole L Mendell; Donald H Bouyer; William L Nicholson; Abelardo C Moncayo; Steven R Meshnick
Journal:  J Clin Microbiol       Date:  2014-09-03       Impact factor: 5.948

6.  Differentiation of rickettsiae by groEL gene analysis.

Authors:  Jung-Hee Lee; Hyo-Soon Park; Won-Jong Jang; Seong-Eun Koh; Jong-Moon Kim; Soo-Kyoung Shim; Mi-Yeoun Park; Yoon-Won Kim; Bum-Joon Kim; Yoon-Hoh Kook; Kyung-Hee Park; Seung-Hyun Lee
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

7.  Detection of Rickettsia prowazekii in body lice and their feces by using monoclonal antibodies.

Authors:  Rong Fang; Linda Houhamdi; Didier Raoult
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

8.  Comparison of serologic typing, sodium dodecyl sulfate-polyacrylamide gel electrophoresis protein analysis, and genetic restriction fragment length polymorphism analysis for identification of rickettsiae: characterization of two new rickettsial strains.

Authors:  L Beati; J P Finidori; B Gilot; D Raoult
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

9.  Comparison of Western immunoblotting and microimmunofluorescence for diagnosis of Mediterranean spotted fever.

Authors:  N Teysseire; D Raoult
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

10.  Zoonotic infections among employees from Great Smoky Mountains and Rocky Mountain National Parks, 2008-2009.

Authors:  Jennifer Adjemian; Ingrid B Weber; Jennifer McQuiston; Kevin S Griffith; Paul S Mead; William Nicholson; Aubree Roche; Martin Schriefer; Marc Fischer; Olga Kosoy; Janeen J Laven; Robyn A Stoddard; Alex R Hoffmaster; Theresa Smith; Duy Bui; Patricia P Wilkins; Jeffery L Jones; Paige N Gupton; Conrad P Quinn; Nancy Messonnier; Charles Higgins; David Wong
Journal:  Vector Borne Zoonotic Dis       Date:  2012-07-26       Impact factor: 2.133
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.